Type II mutations cause a partial loss of NCC function in which the cotransporter is trafficked to the cell surface but has an impaired insertion in the plasma membrane.
Type II mutations lead to a partial loss of NCC function, where the cotransporter is transported to the cell surface but has impaired insertion into the plasma membrane.